iShares Biotechnology ETF (IBB)
$200.02-2.08%Close
SELLBEAR · day 6
Key stats
ETF · income quality metrics
- AUM
- $10.7B
- Expense
- 0.44%
- Yield
- 0.17%
- Quality
- 36
- Beta
- 0.89
- Max DD
- -39.82%
- 1Y
- +32.78%
- 3Y
- +65.09%
- 5Y
- +31.61%
- 1W
- -1.52%
- 1M
- -2.23%
- vs SPY 1W
- -1.38%
- vs SPY 1M
- -4.74%
Industry peers
FMP comparable companies · ranked by market cap
- EWTiShares MSCI Taiwan ETF$12.2B$113.46
- IXNiShares Global Tech ETF$9.2B$147.07
- IOOiShares Global 100 ETF$8.6B$145.95
- IJJiShares S&P Mid-Cap 400 Value ETF$8.4B$141.12
- URTHiShares MSCI World ETF$8.2B$209.16
- IJSiShares S&P Small-Cap 600 Value ETF$7.8B$129.70
- IDViShares International Select Dividend ETF$7.6B$42.15
- IJTiShares S&P Small-Cap 600 Growth ETF$7.6B$161.92
- VOXVanguard Communication Services ETF$6.3B$194.12
- DLNWisdomTree U.S. LargeCap Dividend Fund$6.2B$99.47
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IBB?
- LOPJLB’s latest quantitative signal on iShares Biotechnology ETF (IBB) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is IBB in?
- iShares Biotechnology ETF (IBB) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does iShares Biotechnology ETF (IBB) do?
- The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.